Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials.
Vale C, Godolphin PJ, Fisher D, Horby PW, Kosiborod MN, Hochman JS, Webster K, Higgins JPT, Althouse AD, Berwanger O, Furtado RHM, Gasparyan SB, Haynes R, Koch GG, Landray M, Leifer E, Marshall J, Murthy S, Neal MD, Staplin N, Diaz J, Sterne JAC, Shankar-Hari M; WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group.
Vale C, et al. Among authors: landray m.
Lancet Diabetes Endocrinol. 2024 Oct;12(10):735-747. doi: 10.1016/S2213-8587(24)00219-5. Epub 2024 Sep 6.
Lancet Diabetes Endocrinol. 2024.
PMID: 39250923
Free article.